Todd Allan Penegor, a director at $BROS, bought 2,000 shares of the company on 05-15-2026 for an estimated $102,350. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 59.6%. Following this trade, they now own 5,358 shares of this class of $BROS stock.
$BROS Insider Trading Activity
$BROS insiders have traded $BROS stock on the open market 33 times in the past 6 months. Of those trades, 1 have been purchases and 32 have been sales.
Here’s a breakdown of recent trading of $BROS stock by insiders over the last 6 months:
- TRAVIS BOERSMA (Executive Chairman of Board) has made 0 purchases and 16 sales selling 2,500,000 shares for an estimated $136,924,542.
- TRUST AGGREGATOR, LLC DM has made 0 purchases and 8 sales selling 1,534,786 shares for an estimated $84,059,951.
- INDIVIDUAL AGGREGATOR, LLC DM has made 0 purchases and 8 sales selling 965,214 shares for an estimated $52,864,590.
- TODD ALLAN PENEGOR purchased 2,000 shares for an estimated $102,350
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$BROS Hedge Fund Activity
We have seen 289 institutional investors add shares of $BROS stock to their portfolio, and 247 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 6,567,330 shares (+89.8%) to their portfolio in Q1 2026, for an estimated $332,700,937
- PRICE T ROWE ASSOCIATES INC /MD/ added 4,807,904 shares (+170.2%) to their portfolio in Q1 2026, for an estimated $243,568,416
- NINETY ONE UK LTD removed 2,625,483 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $133,006,968
- FMR LLC added 2,354,015 shares (+32.6%) to their portfolio in Q1 2026, for an estimated $119,254,399
- SQUAREPOINT OPS LLC removed 1,927,464 shares (-67.3%) from their portfolio in Q1 2026, for an estimated $97,645,326
- ALYESKA INVESTMENT GROUP, L.P. added 1,860,182 shares (+inf%) to their portfolio in Q4 2025, for an estimated $113,880,342
- STATE STREET CORP added 1,759,395 shares (+87.1%) to their portfolio in Q1 2026, for an estimated $89,130,950
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$BROS Revenue
$BROS had revenues of $464.4M in Q1 2026. This is an increase of 30.76% from the same period in the prior year.
You can track BROS financials on Quiver Quantitative's BROS stock page.
You can access data on BROS stock through the Quiver Quantitative API.
$BROS Analyst Ratings
Wall Street analysts have issued reports on $BROS in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- DA Davidson issued a "Buy" rating on 03/06/2026
- TD Cowen issued a "Buy" rating on 02/13/2026
- Keybanc issued a "Overweight" rating on 12/17/2025
- Mizuho issued a "Outperform" rating on 12/04/2025
To track analyst ratings and price targets for $BROS, check out Quiver Quantitative's $BROS forecast page.
$BROS Price Targets
Multiple analysts have issued price targets for $BROS recently. We have seen 13 analysts offer price targets for $BROS in the last 6 months, with a median target of $77.0.
Here are some recent targets:
- Christopher Carril from Keybanc set a target price of $79.0 on 05/07/2026
- Jeffrey Bernstein from Barclays set a target price of $75.0 on 05/07/2026
- Jon Tower from Citigroup set a target price of $85.0 on 05/07/2026
- Brian Mullan from Piper Sandler set a target price of $61.0 on 05/07/2026
- Matt Curtis from DA Davidson set a target price of $70.0 on 04/27/2026
- Sarang Vora from Telsey Advisory Group set a target price of $66.0 on 04/08/2026
- Margaret-May Binshtok from Wolfe Research set a target price of $77.0 on 03/09/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
